Adagio Medical Holdings (ADGM) EBIT Margin (2023 - 2024)
Adagio Medical Holdings (ADGM) reported EBIT Margin of 3352.27% for Q3 2024, up 1879651.0% on a YoY basis from N/an in Q4 2023, and down 27.87% sequentially from 2621.65% in Q2 2024.
Adagio Medical Holdings (ADGM) EBIT Margin (2023 - 2024) Analysis & Trends
Adagio Medical Holdings (ADGM) has 2 years of EBIT Margin data on file, last reported at 3352.27% in Q3 2024.
- For the quarter ending Q3 2024, EBIT Margin rose 1879651.0% year-over-year to 3352.27%; the trailing twelve-month figure through Dec 2025 stood at 16517.42% (changed N/A YoY), and the FY2024 full-year result was 23226.77%, down 1391277.0% from the prior year.
- EBIT Margin fell to 3352.27% in Q3 2024, from 2621.65% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 2621.65% in Q2 2024 to a low of 33903.85% in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.02 Bn | 179.73 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 132.07 Bn | 129.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 111.38 Bn | 102.16 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 68.98 Bn | 67.53 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 28.91 Bn | 27.80 Bn | 750.30 Mn | 21.42% |
| 7 | GE HealthCare Technologies | 28.83 Bn | 26.55 Bn | 1.98 Bn | 10.04% |
| 8 | Smith & Nephew | 28.10 Bn | 27.52 Bn | - | - |
| 9 | Koninklijke Philips | 24.30 Bn | 21.26 Bn | 2.01 Bn | 6.17% |
| 10 | Adagio Medical Holdings | 18.88 Mn | 18.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -3,352.27% |
| Jun 30, 2024 | -2,621.65% |
| Mar 31, 2024 | -33,903.85% |
| Dec 31, 2023 | -6,837.18% |
| Sep 30, 2023 | -22,148.78% |